Attitudes toward different formulations of psychotropic drugs: The view of patients and healthcare providers

American Journal of Drug Delivery

Volumn 4, Issue 1, 2006, Pages 33-41

  M̈uller, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; AEROSOL; AGE DISTRIBUTION; ALCOHOLISM; ARTICLE; CHEWING GUM; DRUG CAPSULE; DRUG FORMULATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HUMAN; LOZENGE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERSONALITY DISORDER; POWDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; RATING SCALE; SCHIZOPHRENIA; SEX DIFFERENCE; SUPPOSITORY; TABLET FORMULATION;

EID: 33645285541     PISSN: 11759038     EISSN: 11759038     Source Type: Journal    
DOI: 10.2165/00137696-200604010-00004     Document Type: Article

References (41)

1. Hofer A, Kemmler G, Eder U, et al. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 2004; 65: 932-9
2. Hudson TJ, Owen RR, Thrush CR, et al. A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry 2004; 65: 211-6
3. Mutsatsa SH, Joyce EM, Hutton SB, et al. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatr Scand 2003; 108: 439-46
4. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 2004; 7: 204-15
5. Awad AG, Voruganti LN. New antipsychotics, compliance, quality of life, and subjective tolerability: are patients better off? Can J Psychiatry 2004; 49: 297-302
6. M̈uller MJ, Schlosser R, Kapp-Steen G, et al. Patients' satisfaction with psychiatric treatment: comparison between an open and a closed ward. Psychiatr Q 2002; 73: 93-107
7. Day JC, Bentall RP, Roberts C, et al. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 2005; 62: 717-24
8. Gigantesco A, Picardi A, Chiaia E, et al. Patients' and relatives' satisfaction with psychiatric services in a large catchment area in Rome. Eur Psychiatry 2002; 17: 139-47
9. Erinosho OA, Ayonrinde A. A comparative study of opinion and knowledge about mental illness in different societies. Psychiatry 1978; 41: 403-10
10. Angermeyer MC, Matschinger H. Public attitude toward psychiatric treatment. Acta Psychiatr Scand 1996; 94: 326-36
11. Angermeyer MC, Matschinger H. Lay beliefs about mental disorders: a comparison between the western and the eastern parts of Germany. Soc Psychiatry Psychiatr Epidemiol 1999; 34: 275-81
12. Angermeyer MC, Kenzine DV, Korolenko TP, et al. Opinions on psychiatric diseases of the citizens of Novosibirsk: results of a representative study. Psychiatr Prax 2004; 31: 90-5
13. Gaebel W, Baumann A, Witte AM, et al. Public attitudes toward people with mental illness in six German cities: results of a public survey under special consideration of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2002; 252: 278-87
14. Kurihara T, Kato M, Sakamoto S, et al. Public attitudes toward the mentally ill: a cross-cultural study between Bali and Tokyo. Psychiatry Clin Neurosci 2000; 54: 547-52
15. Althaus D, Stefanek J, Hasford J, et al. Knowledge and attitude of the general public regarding symptoms, etiology and possible treatments of depressive illnesses. Nervenarzt 2002; 73: 659-64
16. Angermeyer MC, Matschinger H. Have there been any changes in the public's attitudes toward psychiatric treatment? Results from representative population surveys in Germany in the years 1990 and 2001. Acta Psychiatr Scand 2005; 111: 68-73
17. Hegerl U, Althaus D, Stefanek J. Public attitudes toward treatment of depression: effects of an information campaign. Pharmacopsychiatry 2003; 36: 288-91
18. Angermeyer MC, Matschinger H. Public attitudes to people with depression: have there been any changes over the last decade? J Affect Disord 2004; 83: 177-82
19. Angermeyer MC, Matschinger H, Sandmann J, et al. Attitude of medical students to treatment with psychotropic drugs. 1: comparison between medical students and the general population. Psychiatr Prax 1994; 21: 58-63
20. Benkert O, Graf-Morgenstern M, Hillert A, et al. Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection. J Nerv Ment Dis 1997; 185: 151-8
21. Hillert A, Sandmann J, Ehmig SC, et al. Psychopharmaceutical drugs in the mass media: results of a systematic analysis of text contents and images. Nervenarzt 1995; 66: 835-44
22. Angermeyer MC, Matschinger H, Holzinger A. Gender and attitudes toward people with schizophrenia: results of a representative survey in the Federal Republic of Germany. Int J Soc Psychiatry 1998; 44: 107-16
23. Jorm AF, Korten AE, Jacomb PA, et al. Helpfulness of interventions for mental disorders: beliefs of health professionals compared with the general public. Br J Psychiatry 1997; 171: 233-7
24. Hillert A, Sandmann J, Angermeyer MC, et al. Attitude of medical students to treatment with psychotropic drugs. 2: change in attitude in the course of medical education. Psychiatr Prax 1994; 21: 64-9
25. Rettenbacher MA, Hofer A, Eder U, et al. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication. J Clin Psychiatry 2004; 65: 1211-8
26. Everitt BS, Landau S, Leese M. Cluster analysis. 4th ed. New York: Oxford University Press, 2001
27. Frijlink HW. Benefits of different drug formulations in psychopharmacology. Eur Neuropsychopharmacol 2003; 13 Suppl. 3: 77-84
28. Behnke K, Sogaard J, Martin S, et al. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. J Clin Psychopharmacol 2003; 23: 358-64
29. Greenblatt DJ, Divoll M, Harmatz JS, et al. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam. J Pharm Sci 1982; 71: 248-52
30. Popa G, Gafitanu E. Oral disintegrating tablets: a new, modern, solid dosage form [in Romanian]. Rev Med Chir Soc Med Nat Iasi 2003; 107: 337-42
31. Bienvenu OJ, Eaton WW. The epidemiology of blood-injection-injury phobia. Psychol Med 1998; 28: 1129-36
32. Nir Y, Paz A, Sabo E, et al. Fear of injections in young adults: prevalence and associations. Am J Trop Med Hyg 2003; 68: 341-4
33. Atreja A, Bellam N, Levy S. Strategies to enhance patient adherence: making it simple. Medscape General Medicine 2005; 7 (1): E1-6
34. Freudenreich O, Cather C, Evins AE, et al. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry 2004; 65: 1372-6
35. Simon AE, Berger GE, Giacomini V, et al. Insight in relation to psychosocial adjustment in schizophrenia. J Nerv Ment Dis 2004; 192: 442-5
36. Jorm AF, Korten AE, Rodgers B, et al. Belief systems of the general public concerning the appropriate treatments for mental disorders. Soc Psychiatry Psychiatr Epidemiol 1997; 32: 468-73
37. Rettenbacher MA, Burns T, Kemmler G, et al. Schizophrenia: attitudes of patients and professional carers toward the illness and antipsychotic medication. Pharmacopsychiatry 2004; 37: 103-9
38. Day JC, Kinderman P, Bentall R. A comparison of patients' and prescribers' beliefs about neuroleptic side-effects: prevalence, distress and causation. Acta Psychiatr Scand 1998; 97: 93-7
39. Norman TR, Olver JS. New formulations of existing antidepressants: advantages in the management of depression. CNS Drugs 2004; 18: 505-20
40. Judge R. Patient perspectives on once-weekly fluoxetine. J Clin Psychiatry 2001; 62 Suppl. 22: 53-7
41. Hofer A, Kemmler G, Eder U, et al. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia. J Clin Psychiatry 2002; 63: 49-53